CRYOPORT, INC. Related Party Transaction, Rate
CRYOPORT, INC. (CYRX) reported Related Party Transaction, Rate of 6.00% for the 12-month period ending 2015-03-31, per its 10-K filed 2015-05-19.
Discontinued › Notes
us-gaap:RelatedPartyTransactionRate · last filed 2015-05-19
- CRYOPORT, INC. related party transaction, rate for the quarter ending 2014-06-30 was 6.00%, a 0.00% change year-over-year.
- CRYOPORT, INC. related party transaction, rate for the quarter ending 2013-06-30 was 6.00%, a 0.00% change year-over-year.
- CRYOPORT, INC. related party transaction, rate for the quarter ending 2012-06-30 was 6.00%.
- CRYOPORT, INC. related party transaction, rate for fiscal 2015 was 6.00%, a 0.00% change from fiscal 2014.
- CRYOPORT, INC. related party transaction, rate for fiscal 2014 was 6.00%, a 0.00% change from fiscal 2013.
- CRYOPORT, INC. related party transaction, rate for fiscal 2013 was 6.00%.
| Period end | Related Party Transaction, Rate 3 month | Related Party Transaction, Rate 6 month | Related Party Transaction, Rate 9 month | Related Party Transaction, Rate 12 month |
|---|---|---|---|---|
| 2015-03-31 | 6.00% 10-K · filed 2015-05-19 | |||
| 2014-12-31 | 6.00% 10-Q · filed 2015-02-05 | |||
| 2014-09-30 | 6.00% 10-Q · filed 2014-11-12 | |||
| 2014-06-30 | 6.00% 10-Q · filed 2014-07-31 | |||
| 2014-03-31 | 6.00% 10-K · filed 2014-06-25 | |||
| 2013-12-31 | 6.00% 10-Q · filed 2014-02-13 | |||
| 2013-09-30 | 6.00% 10-Q · filed 2013-11-18 | |||
| 2013-06-30 | 6.00% 10-Q · filed 2013-08-14 | |||
| 2013-03-31 | 6.00% 10-K · filed 2013-06-25 | |||
| 2012-12-31 | 6.00% 10-Q · filed 2013-02-14 | |||
| 2012-09-30 | 6.00% 10-Q · filed 2012-11-09 | |||
| 2012-06-30 | 6.00% 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |